CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-19 | Lenar Aimee J. President, US Pharma | Sale 10b5-1 | −36,827 | $7.03 | $259K | 334,853 |
| 2026-05-19 | Lee Frank D. Director | Sale 10b5-1 | −24,456 | $5.43 | $133K | 49,339 |
| 2026-03-03 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −4,420 | $5.77 | $26K | 616,761 |
| 2026-03-02 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −6,856 | $5.78 | $40K | 776,076 |
| 2026-02-27 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −8,388 | $5.95 | $50K | 809,258 |
| 2025-09-08 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −13,370 | $7.31 | $98K | 499,585 |
| 2025-08-21 | Lee Frank D. Director | Sale | −15,912 | $7.66 | $122K | 73,795 |
| 2024-12-02 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −440 | $8.35 | $4K | 433,066 |
| 2024-09-06 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −13,370 | $6.21 | $83K | 435,198 |
| 2024-03-04 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −4,420 | $9.80 | $43K | 501,798 |
| 2024-03-04 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −199 | $9.80 | $2K | 501,599 |
| 2024-03-04 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −1,561 | $9.80 | $15K | 500,038 |
| 2024-03-04 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −133 | $9.80 | $1K | 499,905 |
| 2023-12-05 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −220 | $7.38 | $2K | 382,925 |
| 2023-11-06 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −43 | $7.61 | $327 | 384,836 |
| 2023-09-06 | Carson Seana EVP, General Counsel | Sale 10b5-1 | −6,685 | $8.28 | $55K | 385,213 |
| 2023-03-06 | Carson Seana EVP, General Counsel | Sale | −495 | $9.17 | $5K | 443,235 |
| 2023-03-03 | Carson Seana EVP, General Counsel | Sale | −780 | $9.34 | $7K | 443,730 |
| 2023-02-28 | Carson Seana EVP, General Counsel | Sale | −292 | $9.32 | $3K | 359,185 |
| 2022-04-14 | Spurr Robert U.S. President-Pharma Business | Sale | −1,595 | $22.19 | $35K | 90,506 |
Page 1 of 2 · 30 trades